KDS2010 Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
Mild Cognitive Impairment (MCI)Mild DementiaAlzheimer's Disease
NeuroBiogen Co., Ltd114 enrolled8 locationsNCT07027072
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
ObesityOverweightObese Patients
NeuroBiogen Co., Ltd75 enrolled3 locationsNCT07009171